Open AccessProspective Evaluation of Health-Related Quality of Life in Patients with Metastatic Urothelial Carcinoma Undergoing Immunotherapy with Pembrolizumab: Symptom Burden Can Predict Survival
Author(s) -
Laila Schneidewind,
Désirée Louisê Dräger,
Vanessa Roßberg,
Julia Nolting,
Oliver W. Hakenberg
Publication year - 2022
Publication title -
urologia internationalis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.771
H-Index - 53
eISSN - 1423-0399
pISSN - 0042-1138
DOI - 10.1159/000526962
Subject(s) - medicine , quality of life (healthcare) , prospective cohort study , metastatic urothelial carcinoma , pembrolizumab , immunotherapy , oncology , cancer , carcinoma , physical therapy , urothelial carcinoma , bladder cancer , nursing
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom